Ligand Enters into Commercial License and Supply Agreement with Sanofi for Captisol-enabled SAR-125844 July 30, 2015
Revolade® Recommended by CHMP for EU Approval to Treat Patients with Severe Aplastic Anemia, a Serious Blood Disorder July 24, 2015
FDA Approves Promacta® for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication June 12, 2015
Ligand Announces Favorable Results From Phase 1b Trial With LGD-6972 in Type 2 Diabetes and Plans to Initiate a Phase 2 Trial June 7, 2015
Ligand Announces New Time for June 7th Investor Presentation and Webcast at the American Diabetes Association 75th Scientific Sessions June 5, 2015
Ligand Summarizes the Accounting Impact of the Viking Therapeutics, Inc. IPO and Updates 2015 Financial Guidance June 2, 2015
